FMR CORP 13D/13G Filings for

FMR CORP 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-12
09:22 am
Purchase
2024-12-31 13G Teva Pharmaceutical Industries Limited
TEVA
FMR CORP 81,983,229
7.200%
19,242,467increase
(+30.67%)
Filing
2024-11-12
10:34 am
Purchase
2024-11-08 13G Teva Pharmaceutical Industries Limited
TEVA
FMR CORP 62,740,762
5.537%
33,877,274increase
(+117.37%)
Filing